Citius Pharmaceuticals- Warrants(02/08/2022) Minority Interest

The latest minority interest for CTXRW is $9.3M as of June 2026. That compares with $2.5M in the prior-year period — up 271.5% year over year. Investors often review this figure alongside Citius Pharmaceuticals- Warrants(02/08/2022)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, CTXRW's minority interest moved from $2.5M to $9.3M — a 271.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Citius Pharmaceuticals- Warrants(02/08/2022)'s operating scale or balance-sheet position.

A minority interest figure of $9.3M for CTXRW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting CTXRW's minority interest ($9.3M), review year-over-year change from $2.5M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Citius Pharmaceuticals- Warrants(02/08/2022)'s minority interest against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.